Detalhe da pesquisa
1.
Spirooxadiazoline-oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells.
Arch Pharm (Weinheim)
; : e2400029, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627294